IQVIA Holdings Inc. (NYSE:IQV) Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. grew its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 4.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,418,392 shares of the medical research company's stock after purchasing an additional 93,194 shares during the period. IQVIA comprises about 0.9% of Mitsubishi UFJ Asset Management Co. Ltd.'s portfolio, making the stock its 22nd largest position. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 1.33% of IQVIA worth $532,070,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in IQV. AdvisorNet Financial Inc raised its holdings in shares of IQVIA by 327.6% during the fourth quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company's stock worth $29,000 after acquiring an additional 95 shares during the period. BKM Wealth Management LLC acquired a new stake in IQVIA in the 4th quarter valued at $32,000. Activest Wealth Management acquired a new stake in IQVIA in the 4th quarter valued at $35,000. CVA Family Office LLC acquired a new stake in IQVIA in the 4th quarter valued at $43,000. Finally, CoreFirst Bank & Trust acquired a new stake in IQVIA in the 3rd quarter valued at $44,000. 89.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

IQV has been the topic of several recent research reports. Guggenheim lowered shares of IQVIA from a "buy" rating to a "neutral" rating in a research note on Thursday, February 15th. Truist Financial decreased their price objective on shares of IQVIA from $297.00 to $292.00 and set a "buy" rating for the company in a research report on Friday, May 3rd. Robert W. Baird decreased their price objective on shares of IQVIA from $254.00 to $245.00 and set a "neutral" rating for the company in a research report on Friday, May 3rd. StockNews.com raised shares of IQVIA from a "hold" rating to a "buy" rating in a research report on Friday, February 16th. Finally, Evercore ISI decreased their price objective on shares of IQVIA from $275.00 to $250.00 and set an "outperform" rating for the company in a research report on Friday, May 3rd. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, IQVIA has a consensus rating of "Moderate Buy" and an average price target of $257.57.

Insiders Place Their Bets

In other news, insider Eric Sherbet sold 1,000 shares of the business's stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $241.50, for a total value of $241,500.00. Following the completion of the transaction, the insider now directly owns 20,836 shares in the company, valued at approximately $5,031,894. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, insider Eric Sherbet sold 1,000 shares of the business's stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $241.50, for a total value of $241,500.00. Following the completion of the transaction, the insider now directly owns 20,836 shares in the company, valued at approximately $5,031,894. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Ari Bousbib sold 31,678 shares of the company's stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $250.53, for a total transaction of $7,936,289.34. Following the transaction, the insider now owns 796,752 shares of the company's stock, valued at $199,610,278.56. The disclosure for this sale can be found here. Insiders sold 41,285 shares of company stock worth $10,331,003 in the last quarter. 1.60% of the stock is currently owned by corporate insiders.

IQVIA Stock Performance

IQVIA stock traded up $2.53 during midday trading on Wednesday, hitting $233.67. The company's stock had a trading volume of 963,395 shares, compared to its average volume of 960,785. IQVIA Holdings Inc. has a 1-year low of $167.42 and a 1-year high of $261.73. The company has a debt-to-equity ratio of 2.02, a current ratio of 0.88 and a quick ratio of 0.88. The company has a 50-day moving average price of $241.28 and a two-hundred day moving average price of $226.69. The company has a market cap of $42.57 billion, a price-to-earnings ratio of 31.92, a PEG ratio of 2.30 and a beta of 1.52.

IQVIA (NYSE:IQV - Get Free Report) last issued its quarterly earnings data on Wednesday, February 14th. The medical research company reported $2.84 earnings per share for the quarter, topping the consensus estimate of $2.82 by $0.02. IQVIA had a net margin of 9.01% and a return on equity of 29.17%. The business had revenue of $3.87 billion during the quarter, compared to analysts' expectations of $3.80 billion. During the same quarter in the previous year, the company earned $2.54 EPS. The business's revenue was up 3.5% on a year-over-year basis. As a group, sell-side analysts predict that IQVIA Holdings Inc. will post 10.1 earnings per share for the current year.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.